MedPath

Role of Greyscale and Power Doppler Sonography in Therapy Monitoring in Early Rheumatoid Arthritis (RA)

Conditions
Rheumatoid Arthritis
Registration Number
NCT00854243
Lead Sponsor
Cairo University
Brief Summary

The purpose of this study is to evaluate the role of musculoskeletal ultrasound and power Doppler in early therapy monitoring of rheumatoid arthritis patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Adults: age at disease onset >18 years and < 50 years
  • Disease duration < 3 month
  • Fulfilling ARA criteria for classification of RA
  • DMARD naive
Exclusion Criteria
  • Age at diagnosis < 18 years
  • Disease duration > 3 month
  • Previous use of DMARDS
  • Previous use of biologics

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath